Kyverna Therapeutics, Inc. Kyverna Therapeutics Highlights Potential of KYV-101 in Rheumatoid Arthritis with Phase 1 Data from Investigator-Initiated Trial Presented at ACR Convergence 202…
Efforts to Block Zohran Mamdani's Campaign Billionaires have invested over $22 million in campaigns to defeat Democratic nominee Zohran Ma…
Ready to Ditch Windows? A Powerful Mini PC Optimized for Linux The Kubuntu Focus NX Gen 3 comes preloaded with a popular Linux distributio…
Gauhati High Court Extends Interim Protection for Journalist Abhisar Sharma The Gauhati High Court has extended interim protection for jou…
The Most Versatile Linux Distributions Looking for a general, all-purpose Linux OS? These are user-friendly, secure, and suitable for both…
Novartis to Acquire Avidity Biosciences for $12 Billion Novartis has announced an agreement to acquire Avidity Biosciences, a biopharmaceu…
Australia Accuses Microsoft of Misleading Consumers Australia's ACCC has sued Microsoft for allegedly misleading 2.7 million users over AI…
Novartis Acquires Avidity Biosciences for $12bn Novartis has signed an agreement to acquire all outstanding shares of US-based Avidity Bio…
Vodafone Idea Shares Surge After Supreme Court Ruling Vodafone Idea shares jumped 9% after the Supreme Court allowed the government to rec…
FIFA ASEAN Cup Announced for Southeast Asia The tournament was announced during the 47th ASEAN Summit in Kuala Lumpur. FIFA and ASEAN have…
Possibilities for Early Diagnosis of Head and Neck Squamous Cell Carcinoma Head and neck squamous cell carcinoma (HNSCC) is a diverse grou…